A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant)
Clinical trial NCT07349017 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07349017
- Sponsor
- Changchun BCHT Biotechnology Co.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-07
- Primary completion
- 2026-04-25
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.